|
Cancer Treatment for the New Millennium 9th March 2006 |
|
| Programme: | |
| 09.00 | Registration and Coffee |
| Session 1. Chair: Dr Robert Williams, Cancer Research UK | |
| 10.00 |
Professor David E Thurston, London School of Pharmacy, UK. Chemical Approaches to the Discovery and Development of Cancer Therapies. |
| 10.40 |
Dr John Lyons, Astex Therapeutics, UK. Discovery of Novel Targeted Therapies Using Fragment Based Drug Discovery. |
| 11.20 |
Dr David Jenkins, GSK, Belgium. Vaccination with HPV 16/18 L1 Virus-like Particles and the Prevention of Cervical Cancer. |
| 12.00 | Lunch |
| Session 2. Chair: Dr Mark Searcey, University of London, UK | |
| 13.10 |
Professor Herbie Newell, Northern Institute for Cancer Research, UK. The Development of DNA Repair Inhibitors for use in Cancer Chemotherapy. |
| 13.50 |
Dr Nessa Carey, Topotarget, UK. PXD101: A Case History of Histone Deacetylase Inhibitors in Cancer. |
| 14.30 |
Dr Brian Huntley, Cambridge, UK. Cancer Stem Cells: The Reservoir for Growth and Resistance in Malignancies. |
| 15.10 | Tea |
| Session 3. Chair: Professor Barry Potter, University of Bath, UK | |
| 15.40 |
Dr Theresa LaVallee, Entremed, USA. 2ME2 and ENDM-1198: Microtubule Targeting Agents that Downregulate HIF and Inhibit Angiogenesis. |
| 16.20 |
Professor Mike Reed, Imperial College, UK. Steroid Sulfatase Inhibitors: A new Therapy for Breast Cancer. |
| 17.00 | Close |
| Home / Meetings / Membership / Student Bursaries / Administration / History of the SMR / SMR Award / Archive Material / Links / Contact Us |